Brochure
4 Oct 2024

Mérieux NutriSciences | Pharma Service Catalogue

PDF 2.2 MB

Pharmaceutical Laboratory Services - One-stop shop pharma facility.
Mérieux NutriSciences is a valued partner to the global healthcare industry, offering research, development and quality control testing of pharmaceutical products.

From active ingredients to finished products, we offer a complete range of analytical and research services for API and pharmaceutical products.Our services include safety and quality control, development and validation of analytical methods. Our fully equipped, state-of-the-art laboratories offer comprehensive testing services according to the current pharmacopoeia. We also provide tailored solutions according to customer specifications.

Content provided by our supplier

Chelab

  • IT
  • 2020
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Other
Primary activities
Analytical Services
Contract Manufacturer
Laboratory Services

Other Content from Chelab (1)

  • Video Pushing Boundaries in Nitrosamines Analysis: Spotlight on Nitroso Drug Substance-Related Impurities

    The global alert on nitrosamines has profoundly impacted the pharmaceutical industry, necessitating an immediate and comprehensive response from all stakeholders involved. Nitrosamines, which are classified as probable human carcinogens, have historically been associated with the consumption of cured meats and tobacco products, but their unexpected presence in pharmaceuticals prompted a swift reaction from health authorities worldwide. In response to the global nitrosamine alert, Mérieux NutriSciences' Pharmaceutical and R&D Divisions have utilized their extensive expertise to develop advanced methodologies to tackle the challenges posed by nitrosamine impurities. Drawing on a strong background in the chemical industries, their experts have pioneered the use of sophisticated mass spectrometry technologies to improve the detection and quantification of nitrosamines in drug products, aiding pharmaceutical companies in compliance efforts. This year, Sergio Fasan, Business Director will present all the latest research and innovation in our pharmaceutical labs: > NDSRIs emerging issues > Analytical challenges during method development and QC tests on NDSRIs > Case studies from MxNS Pharma Nitrosamines Labs